Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Agonist and Antagonist Effects in Dependence
NCT00142727Phase 2Terminated
- Sponsor
- National Institute on Drug Abuse
- Start
- Jan 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of methadone in opioid use disorder (OUD), sponsored by National Institute on Drug Abuse. Primary endpoints: Opiate withdrawal symptoms, Opiate agonist symptoms and 1 more. Started Jan 2004; status: terminated.
02
Drugs
methadone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00142727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00142727.